(Q30361446)

20 June 2017

2 references

23 October 2022

Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention. (English)

1 reference

20 June 2017

0 references

1 reference

Erik De Clercq

1

0 references

Johan Neyts

object named as

Johan Neyts

series ordinal

2

0 references

language of work or name

1 reference

4 May 2007

1 reference

Trends in Pharmacological Sciences

20 June 2017

1 June 2007

1 reference

23 October 2022

2 references

20 June 2017

23 October 2022

28

1 reference

20 June 2017

issue

6

1 reference

20 June 2017

page(s)

280-285

1 reference

Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors

20 June 2017

cites work

1 reference

12 December 2020

Protection against lethal influenza virus challenge by RNA interference in vivo.

1 reference

12 December 2020

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

1 reference

12 December 2020

A novel class of potent influenza virus inhibitors: polysubstituted acylthiourea and its fused heterocycle derivatives

1 reference

12 December 2020

Inhibition of influenza virus production in virus-infected mice by RNA interference

1 reference

12 December 2020

Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.

1 reference

12 December 2020

Antiviral agents active against influenza A viruses.

1 reference

12 December 2020

Large-scale sequence analysis of avian influenza isolates.

1 reference

12 December 2020

Avian influenza viruses and their implication for human health.

1 reference

12 December 2020

PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice

1 reference

12 December 2020

Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.

1 reference

12 December 2020

Mechanism of action of T-705 against influenza virus

1 reference

12 December 2020

Neuraminidase inhibitors for influenza

1 reference

12 December 2020

Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.

1 reference

12 December 2020

Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.

1 reference

12 December 2020

Inhibition of influenza virus transcription by 2'-deoxy-2'-fluoroguanosine

1 reference

12 December 2020

Oseltamivir resistance during treatment of influenza A (H5N1) infection

1 reference

12 December 2020

Virology. Clues to the virulence of H5N1 viruses in humans

1 reference

12 December 2020

Heterocyclic rimantadine analogues with antiviral activity

1 reference

12 December 2020

Avian flu: influenza virus receptors in the human airway

1 reference

12 December 2020

Inhibition of respiratory viruses by nasally administered siRNA.

1 reference

12 December 2020

Evolution of H5N1 avian influenza viruses in Asia

1 reference

12 December 2020

Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque

1 reference

12 December 2020

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

1 reference

12 December 2020

Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C.

1 reference

12 December 2020

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

1 reference

12 December 2020

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

1 reference

12 December 2020

Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen

1 reference

12 December 2020

In vitro and in vivo influenza virus-inhibitory effects of viramidine

1 reference

12 December 2020

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

1 reference

12 December 2020

Antivirals and antiviral strategies

1 reference

12 December 2020

Absence of interferon in lungs fom fatal cases of influenza

1 reference

12 December 2020

Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice.

1 reference

12 December 2020

Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam.

1 reference

12 December 2020

A novel antiviral agent which inhibits the endonuclease of influenza viruses

1 reference

12 December 2020

In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication

1 reference

12 December 2020

Avian influenza A (H5N1) infection in humans

1 reference

12 December 2020

The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies.

1 reference

12 December 2020

Avian flu: isolation of drug-resistant H5N1 virus.

1 reference

12 December 2020

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

1 reference

12 December 2020

Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses

1 reference

12 December 2020

Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection

1 reference

12 December 2020

The origins of pandemic influenza--lessons from the 1918 virus.

1 reference

12 December 2020

Virus interference. I. The interferon

1 reference

12 December 2020

10.1016/J.TIPS.2007.04.005

Identifiers

DOI

1 reference

20 June 2017

0 references

1 reference